FIGHTING TNBC

In the Heart of Africa

ICART meeting at the Olabisi Onabanjo University Teaching Hospital (OOUTH), Nigeria

BUILDING A GLOBAL CONSORTIUM WITH COLLEAGUES IN AFRICA

With TNBC discriminately affecting women of African origin more than any other ancestral group, it is of paramount importance to build collaborations with colleagues in Africa, where the fruits of our research will arguably have most impact. Working with scientists in Nigeria, ICART partners across the globe will come together to advance knowledge and understanding of TNBC, with the goal to improve treatment outcomes for women around the world. 

ICART Partner Laboratories in Africa

 

  1. KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY, Kumasi , Ghana

  2. OLABISI ONABANJO UNIVERSITY, Sagamu, Nigeria

  3. ME CURE HEALTHCARE LIMITED, Oshodi, Nigeria

  4. LAGOS UNIVERSITY TEACHING HOSPITAL (LUTH), Idi-Araba, Nigeria

  5. LAGOS STATE UNIVERSITY TEACHING HOSPITAL (LASUTH), Ikeja, Nigeria

  6. OBAFEMI AWOLOWO UNIVERSITY, Ile-Ife, Nigeria

  7. EKITI STATE UNIVERSITY, Ado-Ekiti, Nigeria

  8. UNIVERSITY OF BENIN, Benin City, Nigeria

  9. CHUKWUEMEKA ODUMEGWU OJUKWU UNIVERSITY, Uli, Nigeria

  10. NATIONAL HOSPITAL, Abuja, Nigeria

  11. AHMADU BELLO UNIVERSITY, Zaria, Nigeria

  12. UNIVERSITY OF JOS, Jos, Nigeria

  13. BENUE STATE UNIVERSITY, Makurdi, Nigeria

  14. UNIVERSITY OF UYO, Uyo, Nigeria

  15. UNIVERSITY OF MADUGURI, Maiduguri, Nigeria

 

Gallery

Dr. Daramola’s group, Lagos University Teaching Hospital, Nigeria

Ekiti State University, Nigeria

ICART Triple Negative Breast Cancer Research Workshop, July 2016, OOUTH, Nigeria

Dr. Daramola’s group, Lagos University Teaching Hospital, Nigeria

Ekiti State University, Nigeria

ICART Triple Negative Breast Cancer Research Workshop, July 2016, OOUTH, Nigeria